Close

UPDATE: KeyBanc Starts Recursion Pharmaceuticals (RXRX) at Overweight

May 11, 2021 4:32 AM EDT Send to a Friend
(Updated - May 11, 2021 4:55 AM EDT)

KeyBanc analyst Donald Hooker initiates coverage on Recursion Pharmaceuticals (NASDAQ: RXRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login